Abstract
Progress in elucidating the pathobiology of aortic stenosis (AS) and identifying promising therapeutic targets has not yet translated into proven pharmacologic treatment for AS. This review offers practical guidance to address scientific, operational, and trial design challenges and proposes the development of a clinical trials research network to execute a platform trial as the optimal path to efficiently test multiple potential therapies to identify effective ones that can complement mechanical solutions for late-stage disease.
Original language | English |
---|---|
Journal | Journal of the American College of Cardiology |
Publication status | Published - 7 Dec 2021 |